ASLAN Pharmaceuticals Limited Recorded Big Gain
Fri, Nov 22, 2019 at 05:30 PM
ASLAN Pharmaceuticals Limited (ASLN:NASDAQ) soared today at $1.73, representing a gain of 293.2%. The stock appeared on our News Catalysts scanner on Fri 22 Nov 19 at 12:16 PM. From Fri 01 Nov 19, the stock recorded 35.71% Up Days and 26.67% Green Days
About ASLAN Pharmaceuticals Limited (ASLN:NASDAQ)
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
Top 10 Gainers:
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 293.18%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 54.8%
- Stage Stores, Inc. (SSI:NYSE), 37.46%
- Akerna Corp. (KERN:NASDAQ), 35.33%
- CBAK Energy Technology, Inc. (CBAT:NASDAQ), 27.66%
- DelMar Pharmaceuticals, Inc. (DMPI:NASDAQ), 27.43%
- Verastem, Inc. (VSTM:NASDAQ), 24.2%
- OpGen, Inc. (OPGN:NASDAQ), 22.12%
- Akebia Therapeutics, Inc. (AKBA:NASDAQ), 21.68%
- The9 Limited (NCTY:NASDAQ), 21.52%